Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device
Clinical trial NCT04918823 · COMPLETED
Trial details
- NCT number
- NCT04918823
- Sponsor
- Boston Sight
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2023-04-04
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.